Maria-Evangelia Georgitsi

Ms. Maria-Evangelia Georgitsi


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
EGEleni Giannoulis
Eleni Giannoulis
CNChristos Nousis
Christos Nousis
ISIoanna Jonida Sula
Ioanna Jonida Sula
MGMaria-Evangelia Georgitsi
Maria-Evangelia Georgitsi
IMIoannis A. Malogiannis
Ioannis A. Malogiannis
Borderline personality disorder (BPD) is a complex and heterogeneous condition characterized by emotional instability, impulsivity, and impaired regulation of interpersonal relationships. This narrative review integrates findings from recent neuroimaging, neurochemical, and treatment studies to identify core neurobiological mechanisms and highlight translational potential. Evidence from 112 studies published up to 2025 is synthesized, encompassing structural MRI, resting-state and task-based functional MRI, EEG, PET, and emerging machine learning applications. Consistent disruptions are observed across the prefrontal–amygdala circuitry, the default mode network (DMN), and mentalization-related regions. BPD shows a dominant and stable pattern of hyperconnectivity in the precuneus. Transdiagnostic comparisons with PTSD and cocaine use disorder (CUD) suggest partial overlap in DMN dysregulation, though BPD-specific traits emerge in network topology. Machine learning models achieve a classification accuracy of 70–88% and may support the tracking of early treatment responses. Longitudinal fMRI studies indicate that psychodynamic therapy facilitates the progressive normalization of dorsal anterior cingulate cortex (dACC) activity and reductions in alexithymia. We discuss the role of phenotypic heterogeneity (internalizing versus externalizing profiles), the potential of neuromodulation guided by biomarkers, and the need for standardized imaging protocols. Limitations include small sample sizes, a lack of effective connectivity analyses, and minimal multicenter cohort representation. Future research should focus on constructing multimodal biomarker panels that integrate functional connectivity, epigenetics, and computational phenotyping. This review supports the use of a precision psychiatry approach for BPD by aligning neuroscience with scalable clinical tools.

Verified
Journal Article
Open access
PDF file
IMIoannis A. Malogiannis
Ioannis A. Malogiannis
ISIrini Soultani
Irini Soultani
IZIfigeneia Zikou
Ifigeneia Zikou
MGMaria-Evangelia Georgitsi
Maria-Evangelia Georgitsi
IDIoanna Dimitriou
Ioanna Dimitriou
EGEleni Giannoulis
Eleni Giannoulis
Background: Borderline Personality Disorder (BPD) is a growing health concern, characterized by emotional dysregulation, impulsivity, and unstable interpersonal relationships. One of the core features of BPD is self-harm, which has significant implications for clinical management, risk assessment, and treatment planning. Accurate assessment tools are essential in evaluating symptom severity and identifying individuals at high risk of self-injurious behaviors, thereby guiding clinical interventions effectively. This study aimed to assess the psychometric properties, factor structure, and diagnostic utility of the Greek version of the Borderline Personality Disorder Severity Index-IV (BPDSI-IV), providing preliminary evidence for its reliability and validity. Methods: A total of 128 individuals with BPD and 32 healthy controls were assessed using the BPDSI-IV together with the Brief Symptom Inventory-53 (BSI-53), the BPD Checklist, the Rosenberg Self-Esteem Scale, the WHOQOL-BREF, and the Defense Style Questionnaire-40 (DSQ-40). BPD diagnoses were confirmed using the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD). Internal consistency, confirmatory factor analysis (CFA) of previously suggested models, exploratory and confirmatory bifactor modeling, and validity assessments were conducted. Results: The BPDSI-IV showed strong internal consistency (α = 0.92, ωt = 0.96), with most subscales demonstrating adequate reliability. Exploratory bifactor analysis using the Schmid–Leiman transformation supported a model with a dominant severity factor (ωh = 0.69), reinforcing the dimensional nature of BPD. CFA supported this bifactorial approach. BPDSI-IV scores significantly discriminated BPD patients from controls (p < 0.001). Strong correlations with measures of psychopathology and self-esteem, and correlations with quality of life further supported its validity. Conclusions: The Greek BPDSI-IV demonstrated strong reliability and validity indicators. Structured assessment tools, such as the BPDSI-IV, can enhance early intervention and research on the course of borderline personality disorder symptoms.